Simplex Trading’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-59,300
| Closed | -$154K | – | 9997 |
|
|
2025
Q4 | $154K | Sell |
59,300
-5,000
| -8% | -$10.1K | ﹤0.01% | 4504 |
|
|
2025
Q3 | $113K | Buy |
64,300
+60,700
| +1,686% | +$97.2K | ﹤0.01% | 5602 |
|
|
2025
Q2 | $5K | Buy |
+3,600
| New | +$4.7K | ﹤0.01% | 7765 |
|
|
2025
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 9492 |
|
|
2024
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 8306 |
|
|
2024
Q3 | $3K | Buy |
+1,000
| New | +$3.29K | ﹤0.01% | 7881 |
|
|
2024
Q2 | – | Sell |
-3,500
| Closed | -$16K | – | 9655 |
|
|
2024
Q1 | $16K | Sell |
3,500
-300
| -8% | -$1.92K | ﹤0.01% | 7280 |
|
|
2023
Q4 | $27K | Sell |
3,800
-50,700
| -93% | -$284K | ﹤0.01% | 6675 |
|
|
2023
Q3 | $658K | Buy |
54,500
+53,800
| +7,686% | +$555K | ﹤0.01% | 3101 |
|
|
2023
Q2 | $7K | Buy |
700
+400
| +133% | +$4.12K | ﹤0.01% | 7711 |
|
|
2023
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 8519 |
|
|
2022
Q4 | $4K | Sell |
300
-800
| -73% | -$12K | ﹤0.01% | 8251 |
|
|
2022
Q3 | $13K | Sell |
1,100
-300
| -21% | -$3.86K | ﹤0.01% | 8006 |
|
|
2022
Q2 | $19K | Buy |
+1,400
| New | +$16.5K | ﹤0.01% | 7679 |
|
Simplex Trading's RPTX Position: Q3 2025 in Review
Simplex Trading sold out of Repare Therapeutics (RPTX) in Q3 2025, closing a stake of 8,093 shares — an estimated $13K sold.
Simplex Trading first reported a position in RPTX in Q4 2021 and held it in 15 quarters. The position peaked at $233K in Q3 2023. 45 funds tracked by Wall St. Rank hold RPTX as of Q3 2025.
- Simplex Trading reported no remaining Repare Therapeutics position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 8,093 Repare Therapeutics shares in Q3 2025, an estimated $13K.
- Simplex Trading first reported a position in Repare Therapeutics in Q4 2021 and held it in 15 quarters.
- Simplex Trading's Repare Therapeutics position peaked at $233K in Q3 2023.
- 45 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.